Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 611,000 | 713,300 | 786,000 | 1,970,000 | 663,100 |
| Receivables | 3,673,200 | 3,523,500 | 3,427,000 | 2,895,100 | 2,709,100 |
| Inventories | 2,422,200 | 2,327,100 | 2,213,000 | 2,390,900 | 2,086,300 |
| Other current assets | 746,100 | 684,200 | 595,000 | 948,400 | 872,500 |
| TOTAL | $7,452,500 | $7,248,100 | $7,021,000 | $8,204,400 | $6,331,000 |
| Non-Current Assets | |||||
| PPE Net | 2,599,700 | 2,563,300 | 2,578,000 | 2,599,300 | 2,451,600 |
| Intangibles | 35,421,100 | 35,382,000 | 35,297,000 | 36,102,400 | 32,389,000 |
| Other Non-Current Assets | 1,040,400 | 1,020,200 | 1,012,000 | 1,104,600 | 1,081,800 |
| TOTAL | $39,061,200 | $38,965,500 | $38,887,000 | $39,806,300 | $35,922,400 |
| Total Assets | $46,513,700 | $46,213,600 | $45,908,000 | $48,010,700 | $42,253,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 982,200 | 1,031,000 | 926,000 | 941,700 | 846,500 |
| Accrued Expenses | 612,600 | 520,800 | 709,000 | 611,200 | 521,600 |
| TOTAL | $5,075,800 | $5,302,900 | $4,866,000 | $5,259,900 | $5,528,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,255,700 | 15,188,400 | 15,372,000 | 16,940,400 | 11,631,900 |
| Deferred Revenues | 542,100 | 538,900 | 486,000 | 492,200 | 358,500 |
| Other Non-Current Liabilities | 1,470,200 | 1,463,700 | 1,573,000 | 1,436,800 | 1,347,900 |
| TOTAL | $19,046,300 | $19,115,500 | $19,502,000 | $21,092,200 | $15,461,300 |
| Total Liabilities | $24,122,100 | $24,418,400 | $24,368,000 | $26,352,100 | $20,989,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 390,120 | 391,220 | 390,391 | 395,025 | 394,263 |
| Common Shares | 416,900 | 416,400 | 415,000 | 415,000 | 414,000 |
| Retained earnings | 14,972,300 | 14,419,400 | 13,927,000 | 13,356,500 | 12,942,500 |
| Other shareholders' equity | -2,255,800 | -2,473,600 | -2,636,000 | -2,155,000 | -2,082,500 |
| TOTAL | $22,391,600 | $21,795,200 | $21,540,000 | $21,658,600 | $21,263,900 |
| Total Liabilities And Equity | $46,513,700 | $46,213,600 | $45,908,000 | $48,010,700 | $42,253,400 |